There is increasing evidence of neurological manifestations and complications in patients
with coronavirus disease 19 (COVID-19). More than one-quarter of patients with COVID-19 …

Abstract Coronavirus disease 2019 (COVID-19), a disease caused by the novel
betacoronavirus (SARS-CoV-2), has become a global pandemic threat. The potential …

Aim of the study In December 2019, a highly pathogenic coronavirus called SARS-CoV-2
(formerly identified as 2019-nCoV) appeared in Wuhan, China, and has since been …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emerged
coronavirus, has sparked a global pandemic with its airborne transmission and ability to …

ABSTRACT Coronavirus disease (COVID-19) arising from severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) viral infection has caused a worldwide pandemic …

First in 2002, severe acute respiratory syndrome coronavirus (SARS-CoV), second in 2012,
Middle East respiratory syndrome coronavirus (MERS-CoV), and now the third in the …

The current pandemic caused by the new severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has become a public health emergency. To date, March 1, 2021, coronavirus …

SARS-CoV-2 infects cells through angiotensin-converting enzyme 2 (ACE2), a ubiquitous
receptor that interacts with the virus' surface S glycoprotein. Recent reports show that the …

A pandemic due to novel coronavirus arose in mid-December 2019 in Wuhan, China, and in
3 months' time swept the world. The disease has been referred to as COVID-19, and the …

Along with emergence of the novel severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in late 2019, a myriad of neurologic symptoms, associated with structural brain …